Neuroprotection in experimental stroke in the rat with an IgG-erythropoietin fusion protein

Brain Research

Volumn 1360, Issue , 2010, Pages 193-197

  Fu, Ailing ^a   Hui, Eric Ka Wai ^b   Lu, Jeff Zhiqiang ^b   Boado, Ruben J ^a,b   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ArmaGen Technologies Inc   (United States)

Author keywords

Blood brain barrier; Erythropoietin; Stroke; Trojan horse

Indexed keywords

ERYTHROPOIETIN; HYBRID PROTEIN; IMMUNOGLOBULIN G; INSULIN RECEPTOR; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN INFARCTION; DRUG ACTIVITY; DRUG MEGADOSE; DRUG PENETRATION; DRUG TRANSPORT; HEART STROKE VOLUME; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; STROKE;

ANIMALS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN, RECOMBINANT; FUNCTIONAL LATERALITY; IMMUNOGLOBULIN G; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; STEREOTAXIC TECHNIQUES; STROKE;

EQUIDAE; RATTUS;

EID: 77957944896     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.09.009     Document Type: Article

References (23)

1. W.A. Banks, N.L. Jumbe, C.L. Farrell, M.L. Niehoff, and A.C. Heatherington Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa Eur. J. Pharmacol. 505 2004 93 101
2. M. Bernaudin, H.H. Marti, S. Roussel, D. Divoux, A. Nouvelot, E.T. MacKenzie, and E. Petit A potential role for erythropoietin in focal permanent cerebral ischemia in mice J. Cereb. Blood Flow Metab. 19 1999 643 651
3. R.J. Boado, E.K. Hui, J.Z. Lu, and W.M. Pardridge Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse J. Pharmacol. Exp. Ther. 333 2010 961 969
4. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. deLanerolle, C. Cerami, L.M. Itri, and A. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc. Natl Acad. Sci. USA 97 2000 10526 10531
5. S.T. Carmichael Rodent models of focal stroke: size, mechanism, and purpose NeuroRx 2 2005 396 409
6. M. Celik, N. Gokmen, S. Erbayraktar, M. Akhisaroglu, S. Konakc, C. Ulukus, S. Genc, K. Genc, E. Sagiroglu, A. Cerami, and M. Brines Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury Proc. Natl Acad. Sci. USA 99 2002 2258 2263
7. H. Ehrenreich, K. Weissenborn, H. Prange, D. Schneider, C. Weimar, K. Wartenberg, P.D. Schellinger, M. Bohn, H. Becker, M. Wegrzyn, P. Jahnig, M. Herrmann, M. Knauth, M. Bahr, W. Heide, A. Wagner, S. Schwab, H. Reichmann, G. Schwendemann, R. Dengler, A. Kastrup, and C. Bartels Recombinant human erythropoietin in the treatment of acute ischemic stroke Stroke 40 2009 e647 e656
8. G. Grasso, A. Sfacteria, F. Meli, V. Fodale, M. Buemi, and D.G. Lacopino Neuroprotection by erythropoietin administration after experimental traumatic brain injury Brain Res. 1182 2007 99 105
9. S.E. Juul, R.J. McPherson, F.X. Farrell, L. Jolliffe, D.J. Ness, and C.A. Gleason Erythropoietin concentrations in cerebrospinal fluid of nonhuman primates and fetal sheep following high-dose recombinant erythropoietin Biol. Neonate 85 2004 138 144
10. M. Kawata, S. Takamoto, K. Kitahori, H. Tsukihara, T. Morota, M. Ono, N. Motomura, A. Murakami, and Y. Suematsu Erythropoietin protects the central nervous system during prolonged hypothermic circulatory arrest: an experimental study in a canine model J. Thorac. Cardiovasc. Surg. 131 2006 1331 1337
11. L.L. Latour, D.W. Kang, M.A. Ezzeddine, J.A. Chalela, and S. Warach Early blood-brain barrier disruption in human focal brain ischemia Ann. Neurol. 56 2004 468 477
12. T. Lieutaud, P.J.D. Andrews, J.K.J. Rhodes, and R. Williamson Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1β and MIP-2 in rats J. Neurotrauma 25 2008 1179 1185
13. P. Mayeux, C. Billat, and R. Jacquot The erythropoietin receptor of rat erythroid progenitor cells J. Biol. Chem. 262 1987 13985 13990
14. E. Morishita, S. Masuda, M. Nagao, Y. Yasuda, and R. Sasaki Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death Neuroscience 76 1997 105 116
15. W.M. Pardridge Re-engineering biopharmaceuticals for delivery to brain with molecular Trojan horses Bioconjug. Chem. 19 2008 1327 1338
16. W.M. Pardridge, Y.S. Kang, J.L. Buciak, and J. Yang Human insulin receptor monoclonal antibody undergoes high affinity binding to human brain capillaries in vitro and rapid transcytosis through the blood-brain barrier in vivo in the primate Pharm. Res. 12 1995 807 816
17. H. Reiber, and K. Felgenhauer Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system Clin. Chim. Acta 163 1987 319 328
18. M. Sakanaka, T.C. Wen, S. Matsuda, S. Masuda, E. Morishita, M. Nagao, and R. Sasaki In vivo evidence that erythropoietin protects neurons from ischemic damage Proc. Natl Acad. Sci. USA 95 1998 4635 4640
19. B.-W. Song, H.V. Vinters, W.M. Pardridge, and D. Wu Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector J. Pharmacol. Exp. Ther. 301 2002 605 610
20. L. Wei, B.H. Han, Y. Li, C.L. Keogh, D.M. Holtzman, and S.P. Yu Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats J. Pharmacol. Exp. Ther. 317 2006 109 116
21. Y.Q. Xue, L.R. Zhao, W.P. Guo, and W.M. Duan Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson's disease Neuroscience 146 2007 1245 1258
22. Y. Zhang, and W.M. Pardridge Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin Brain Res. 889 2001 49 56
23. J.A. Zivin Factors determining the therapeutic window for stroke Neurology 50 1998 599 603